121 related articles for article (PubMed ID: 11006131)
1. Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells.
Jiang C; Agarwal R; Lü J
Biochem Biophys Res Commun; 2000 Sep; 276(1):371-8. PubMed ID: 11006131
[TBL] [Abstract][Full Text] [Related]
2. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo.
Toi M; Bando H; Ramachandran C; Melnick SJ; Imai A; Fife RS; Carr RE; Oikawa T; Lansky EP
Angiogenesis; 2003; 6(2):121-8. PubMed ID: 14739618
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
[TBL] [Abstract][Full Text] [Related]
4. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
Shekhar MP; Werdell J; Tait L
Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
6. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
7. Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation.
Jiang C; Ganther H; Lu J
Mol Carcinog; 2000 Dec; 29(4):236-50. PubMed ID: 11170262
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
9. In vitro anti-proliferative activities of ellagic acid.
Losso JN; Bansode RR; Trappey A; Bawadi HA; Truax R
J Nutr Biochem; 2004 Nov; 15(11):672-8. PubMed ID: 15590271
[TBL] [Abstract][Full Text] [Related]
10. VEGF is upregulated in a neuroblastoma and hepatocyte coculture model.
Beierle EA; Strande LF; Berger AC; Chen MK
J Surg Res; 2001 May; 97(1):34-40. PubMed ID: 11319877
[TBL] [Abstract][Full Text] [Related]
11. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic efficacy of grape seed extract in endothelial cells.
Agarwal C; Singh RP; Dhanalakshmi S; Agarwal R
Oncol Rep; 2004 Mar; 11(3):681-5. PubMed ID: 14767522
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine.
Albini A; Morini M; D'Agostini F; Ferrari N; Campelli F; Arena G; Noonan DM; Pesce C; De Flora S
Cancer Res; 2001 Nov; 61(22):8171-8. PubMed ID: 11719447
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
16. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of thrombin-induced angiogenesis.
Maragoudakis ME; Tsopanoglou NE; Andriopoulou P
Biochem Soc Trans; 2002 Apr; 30(2):173-7. PubMed ID: 12023846
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor.
Yu A; Somasundar P; Balsubramaniam A; Rose AT; Vona-Davis L; McFadden DW
J Surg Res; 2002 Jun; 105(1):65-8. PubMed ID: 12069504
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
